How to Buy Collplant Biotechnologies Stock
Collplant Biotechnologies Ltd
CollPlant Biotechnologies Ltd. , a regenerative and aesthetic medicine company, focuses on three-dimensional (3D) bioprinting of tissues and organs, and medical aesthetics in the United States, Canada, and Europe.
Collplant Biotechnologies stock last closed at $2.12, down 4.29% from the previous day, and has decreased 63.95% in one year. It has overperformed other stocks in the Biotechnology industry by 0.13 percentage points. Collplant Biotechnologies stock is currently +6% from its 52-week low of $2.00, and -68.59% from its 52-week high of $6.75.
As of Apr 30, 2025, there are 11.45M shares of CLGN outstanding. The market cap of CLGN is $24.28M. In the last 24 hours, 13,007 CLGN shares were traded.
How to Buy Collplant Biotechnologies Stock
Wondering how to invest in Collplant Biotechnologies stock? Here's how.
- Choose where to buy Collplant Biotechnologies stock: You need to decide on an online brokerage, but don't worry - we've sifted through dozens of stock brokerages and apps to help you determine where to buy Collplant Biotechnologies stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Deposit funds into your brokerage account: Pick your payment method and add your information.
- Evaluate Collplant Biotechnologies stock: The Collplant Biotechnologies ticker symbol is CLGN. Is Collplant Biotechnologies stock a good investment? Should you buy shares of CLGN? How do CLGN's underlying business fundamentals look? Do top analysts think Collplant Biotechnologies is a good buy? Why has CLGN's stock price moved recently? (Hint: Our stock market research website can help you decide if CLGN is a good stock to buy).
- Make your CLGN trade: Decide if you will purchase CLGN shares at the current market price or use a limit order to purchase CLGN shares at a particular price.
- Get updates on your CLGN investment: Create a watchlist to important updates regarding your new investment in Collplant Biotechnologies shares.
Step 1: Choose where to buy Collplant Biotechnologies stock
You will need an online brokerage account in order to access the NASDAQ market and buy CLGN shares.
Our preferred brokerage: eToro
Based on our research, eToro is the best brokerage. eToro gives you:
- You can invest in stocks with 0% commissions: Invest without paying trading commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world financial markets: From Tech to Healthcare, New York to Tokyo (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading stock exchanges.
- Social investing: eToro offers a community of more than 20 million users globally. Talk to, learn from, and copy the crypto trades of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other financial assets: Such as ETFs and cryptos.
Get $10 towards your purchase of shares by opening an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've picked the right brokerage, you need to fill out some personal details so you are able to buy CLGN today.
How to Create a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Input your personal info to create your new brokerage account.
- Send your data by clicking the "Create Account" button. Get started with eToro today
Step 3: Deposit funds into your brokerage account
Now that you have created your account on the best stock buying app, you can securely and quickly fund your account:
Check out the tutorial below if you need help transferring funds into your investment account.
Step 4: Evaluate Collplant Biotechnologies stock
Once you have identified the best place to buy Collplant Biotechnologies stock, it's important to evaluate their stock before you buy, so you truly understand the risk as well as the upside.
Collplant Biotechnologies shares data
CLGN Due Diligence Score
WallStreetZen was built to help average investors do more accurate fundamental analysis in less time.
You can see all of the due diligence checks on CLGN's stock page.
Is CLGN stock overvalued?
Analysts use many financial metrics, analyses, models, and charts to gauge CLGN's true value.
Using relative valuations metrics:
- CLGN could be undervalued based on its P/B ratio of 1.8x, relative to Biotechnology industry P/B ratio of 4.45x
You can do more valuation analysis on CLGN's stock here.
CLGN Financial Health
Positive Financial Indicators:
- CLGN has a low debt to equity ratio of 0.39.
- Total CLGN debt is lower than 5 years ago, relative to shareholder equity.
- There are more short-term assets than long-term liabilities on the CLGN balance sheet.
- CLGN has $11.91M in cash and short term investments. This is enough to cover its annual cash burn of $14.58M.
- There are more short-term assets than short-term liabilities on the CLGN balance sheet.
Negative Financial Indicators:
- CLGN profit margin has gone down from -64% to -3,225% in the past year.
- CLGN has cash burn of 14575000. It does not have enough cash and short-term investments to cover this.
Is it a good time to buy Collplant Biotechnologies stock, according to analysts?
Out of 2 Wall Street analysts who give forecasts on CLGN, the consensus analyst rating on Collplant Biotechnologies is a Strong Buy
Please keep in mind that analyst forecasts are not stock recommendations, nor are they investment advice.
You can dive deeper into what analysts are projecting on the Collplant Biotechnologies stock forecast page.
CLGN Technical Indicators
Is CLGN Making Money?
Last year, CLGN revenue was $515.00k. In the last five year, CLGN's revenue has gone up by -25.98% per year. This was slower than the Biotechnology industry average of 45.66%.
Dig into CLGN's earnings and revenue performance here.
Latest Insiders Trades at CLGN
Over the last year, executives and large shareholders at CLGN have not bought or sold any shares.
Dig into more about who owns CLGN shares here.
Can I get consistent income from CLGN stock?
No, Collplant Biotechnologies doesn't provide an income stream by paying out dividends.
What do other investors have to say about CLGN?
One of the reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other community members have to say.
Step 5: Make your CLGN trade
There are two primary options:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are usually fine. - Limit order: A limit order is an order to buy or sell a security at a specific price (or better).
If you want to be certain you're buying or selling at a specific price, use a limit order.
Press the Open button and eToro will execute the order.
If you need more assistance buying stocks on eToro, click the how to video below:
Step 6: Get updates on your CLGN investment
Now that you own some CLGN shares, you'll want to stay up-to-date on your stock purchase.
Make a watchlist to monitor your CLGN stock.
CLGN Feed
How to Buy Stock in Collplant Biotechnologies
To reiterate, here are the 6 steps you need to take to buy Collplant Biotechnologies stock right now:
- Choose where to buy Collplant Biotechnologies stock
- Sign up for a brokerage account
- Deposit funds into your brokerage account
- Evaluate Collplant Biotechnologies stock
- Make your CLGN trade
- Get updates on your CLGN investment
If you need a place to buy stocks, eToro is our favorite venue.
Get Started with eToro TodayIf you want to get notifications regarding your investment in Collplant Biotechnologies, get started below.
Trending Articles
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.